Revolution Medicines (RVMD) Net Margin (2019 - 2023)

Revolution Medicines' Net Margin history runs 5 years deep, the most recent figure standing at 21770.49% for Q4 2023.

• In Q4 2023, Net Margin fell 2140175.0% year-over-year to 21770.49%; the TTM figure through Sep 2024 stood at 76423.32% (down 7515705.0% YoY), while the FY2023 annual figure was 3768.28%, down 306533.0% from the prior year.
• Net Margin was 21770.49% for Q4 2023 at Revolution Medicines, down from 2570.55% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 97.27% in Q1 2019 to a low of 21770.49% in Q4 2023.
• Historically, Net Margin has averaged 1952.74% across 5 years, with a median of 390.86% in 2020.
• The sharpest annual moves came in 2022 and 2023: Net Margin jumped 262334 bps in 2022, then sank 2140175 bps in 2023.
• A 5-year view of Net Margin shows it stood at 155.91% in 2019, then slumped by 151 bps to 390.86% in 2020, then plunged by 42 bps to 556.83% in 2021, then soared by 34 bps to 368.73% in 2022, then sank by 5804 bps to 21770.49% in 2023.
• The last three Net Margin figures came in at 21770.49% (Q4 2023), 2570.55% (Q2 2023), and 970.89% (Q1 2023), per Business Quant data.